European phase 3/3b experience with long-acting cabotegravir and rilpivirine: efficacy, safety and virologic outcomesJ. -M. Molina,M. L. Montes,S. Esser,N. De Castro,P. Patel, S. Dakhia, J. W. Polli,L. Garside,R. D'Amico,C. Talarico,V. Van Eygen,K. Vandermeulen, W. R. Spreen, M. Aboud,M. BosseHIV MEDICINE(2021)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要